Generics - Financial, Generics

Filter

Current filters:

FinancialGenerics

Popular Filters

1 to 25 of 208 results

USA’s generic pharma savings reach highest-ever watermark

USA’s generic pharma savings reach highest-ever watermark

15-09-2014

The US Generic Pharmaceutical Association (GPhA) last week released a report showing that generic drugs…

BiosimilarsFinancialGenericsMarkets & MarketingUSA

Prosonix’ generic version of GSK’s Flixotide Evohaler under review in EU

Prosonix’ generic version of GSK’s Flixotide Evohaler under review in EU

02-09-2014

UK-based Prosonix, a speciality pharmaceutical company developing a portfolio of inhaled respiratory…

EuropeEvohalerFinancialFluticasone PropionateGenericsGlaxoSmithKlineMylanProsonixRegulationRespiratory and Pulmonary

Indian Pharma increasing capital and research spending

Indian Pharma increasing capital and research spending

28-08-2014

With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian…

CiplaDr Reddy's LaboratoriesFinancialGenericsGlenmark PharmaceuticalsIndiaLupinMergers & AcquisitionsResearchSun Pharmaceuticals

EMS Group inaugurates NovaMed/EMS, Manaus' first pharmaceutical factory

EMS Group inaugurates NovaMed/EMS, Manaus' first pharmaceutical factory

27-08-2014

Brazilian Minister of Health Arthur Chioro participated in the inauguration ceremony of NovaMed/EMS,…

BrazilEMS GroupFinancialGenericsNovaMedProduction

Indian pharmaceutical sector to see strong growth, says Moody’s

Indian pharmaceutical sector to see strong growth, says Moody’s

25-08-2014

Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double…

FinancialGenericsIndiaMarkets & MarketingMergers & Acquisitions

Hikma's profits boosted in first half by good injectables sales

Hikma's profits boosted in first half by good injectables sales

20-08-2014

Revenue for Jordanian drugmaker Hikma Pharmaceuticals in the first half of 2014 rose 16% following a…

FinancialGenericsHikma PharmaceuticalsJordan

PHARMAC tender for generic medicines contributes NZ$38 million savings

PHARMAC tender for generic medicines contributes NZ$38 million savings

18-08-2014

New Zealanders’ use of generic medicines is likely to grow further following the just-completed 2013/14…

Atypical antipsychoticsFinancialGenericsHealthcareNew Zealand

Despite difficult environment, Stada Arz posts solid results

Despite difficult environment, Stada Arz posts solid results

11-08-2014

German generic and branded drugmaker Stada Arzneimittel says that, in the first half of 2014, the group’s…

Business FinanceFinancialGenericsGermanyGermanySTADA Arzneimittel

Mylan’s 2nd-qtr earnings plunge on higher costs and product approval delays

Mylan’s 2nd-qtr earnings plunge on higher costs and product approval delays

07-08-2014

US generics major Mylan has reported that profits dropped nearly 30% in the second quarter of 2014, despite…

Business FinanceChief executiveFinancialFinancial ratiosFundamental analysisGenericsHeather BreschMylanUSA

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

31-07-2014

Israel’s Teva Pharmaceutical Industries, the world’s biggest generics drugmaker, reported disappointing…

CopaxoneFinancialGenericsIsraelTeva Pharmaceutical Industries

Dr Reddy’s achieves quarterly earnings growth of over 50%

Dr Reddy’s achieves quarterly earnings growth of over 50%

31-07-2014

Indian pharmaceutical company Dr Reddy’s has announced quarterly sales of 35.2 billion rupees.

Business FinanceDr Reddy's LaboratoriesFinancialFundamental analysisGenericsHealth Medical PharmaIndia

Ranbaxy down on same quarter last year following FDA fine

Ranbaxy down on same quarter last year following FDA fine

30-07-2014

Indian generic pharma company Ranbaxy, has reported consolidated sales of 23.7 billion rupees ($394 million),…

BSE SensexFinancialGenericsIndiaOver-the-counter accountingPharmaceutical industryRanbaxyRanbaxy Laboratories

Glenmark reports strong growth everywhere but the USA

Glenmark reports strong growth everywhere but the USA

25-07-2014

India-based generics manufacturer Glenmark has seen its consolidated revenue increase by more than 20%…

FinancialGenericsGlenmark PharmaceuticalsIndia

South Africa’s NAPM calls for elimination of VAT on medicines

22-07-2014

South African trade group the National Association of Pharmaceutical Manufacturers (NAPM) has proposed…

FinancialGenericsNational Association of Pharmaceutical ManufacturersPoliticsPricingSouth Africa

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

14-07-2014

Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

Cipla to invest £100 million in its UK subsidiary

Cipla to invest £100 million in its UK subsidiary

07-07-2014

Indian drugmaker Cipla has decided to make a significant investment in its UK subsidiary over the next…

CiplaFinancialGenericsMarkets & MarketingResearchUK

Stada will continue to develop emerging markets as domestic growth drops

Stada will continue to develop emerging markets as domestic growth drops

05-06-2014

German generic and branded drugmaker Stada Arzneimittel’s executive board chairman, Hartmut Retzlaff,…

Business FinanceBusiness FinanceFinancialGenericsGermanyPharmaceuticalSTADA ArzneimittelSTADA Pharmaceuticals

Australian Audit Commission’s “nuclear option to attack the PBS is madness”

Australian Audit Commission’s “nuclear option to attack the PBS is madness”

05-05-2014

The Australian National Commission of Audit’s complete dismantling and destruction of the Pharmaceutical…

AustraliaFinancialGenericsHealthcarePolitics

Teva 1st-qtr 2014 boosted by new generics

Teva 1st-qtr 2014 boosted by new generics

01-05-2014

Israel generic giant Teva Pharmaceutical Industries reported a 2% rise in revenues to $5.0 billion for…

FinancialGenericsTeva Pharmaceutical Industries

Mylan 1st-qtr 2014 revenues miss analysts’ expectations

Mylan 1st-qtr 2014 revenues miss analysts’ expectations

01-05-2014

US generic drugmaker Mylan reported first-quarter 2014 results before markets opened, posting adjusted…

FinancialGenericsMylan

Actavis swings into profit as 1st-qtr 2014 sales leap 40%

Actavis swings into profit as 1st-qtr 2014 sales leap 40%

30-04-2014

Ireland headquartered generics giant Actavis saw its shares rise 2.6% to $203 in mid-morning trading,…

ActavisFinancialGenerics

Philippine government increasing financial support for health care spending

28-03-2014

The size of the Philippine pharmaceutical market, now worth around $3.2 billion, is expected to expand…

Asia-PacificFinancialGenericsMarkets & MarketingPharmaceutical

1 to 25 of 208 results

Back to top